Lactic acidosis in a patient with type 2 diabetes mellitus

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 8, 2015, Pages 1476-1483

  Weisberg, Lawrence S ^a  

^a Cooper University Health Care ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; DOBUTAMINE; FUROSEMIDE; LEVOFLOXACIN; METRONIDAZOLE; NORADRENALIN; VANCOMYCIN; ANTIDIABETIC AGENT; BICARBONATE; BIOLOGICAL MARKER; METFORMIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOMEGALY; CASE REPORT; CENTRAL VENOUS PRESSURE; CONGESTIVE HEART FAILURE; DYSPNEA; ENDOTRACHEAL TUBE; HEART RATE; HEART RHYTHM; HUMAN; LACTIC ACIDOSIS; MALE; METABOLIC ACIDOSIS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OLIGURIA; OXYGEN SATURATION; RESPIRATORY DISTRESS; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; URINE VOLUME; ACID BASE BALANCE; ACIDOSIS, LACTIC; BLOOD; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; FATALITY; HEMODIALYSIS; TREATMENT OUTCOME;

ACID-BASE EQUILIBRIUM; ACIDOSIS, LACTIC; BIOMARKERS; DIABETES MELLITUS, TYPE 2; FATAL OUTCOME; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; RENAL DIALYSIS; SODIUM BICARBONATE; TREATMENT OUTCOME;

EID: 84938824827     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10871014     Document Type: Article

References (59)

1. Kraut JA,Madias NE: Serum anion gap: Its uses and limitations in clinical medicine. Clin J Am Soc Nephrol 2: 162-174, 2007
2. Gabow PA, Kaehny WD, Fennessey PV, Goodman SI, Gross PA, Schrier RW: Diagnostic importance of an increased serum anion gap. N Engl J Med 303: 854-858, 1980
3. Peixoto AJ, Alpern RJ: Treatment of severe metabolic alkalosis in a patient with congestive heart failure. Am J Kidney Dis 61: 822-827, 2013
4. DuBose TD: Disorders of acid-base balance. In: Brenner & Rector's The Kidney, 9th Ed., edited by Maarten WT, Chertow GM, Marsden PA, Skorecki K, Yu ASL, Brenner BM, Philadelphia, Saunders, 2012, pp 595-639.
5. TangWHW, Francis GS: Clinical evaluation of heart failure. In: Heart Failure: A Companion to Braunwald's Heart Disease, 2nd Ed., edited by Mann DL, Philadelphia, Saunders, 2010, p 516
6. Moe OW, Fuster D: Clinical acid-base pathophysiology: Disorders of plasma anion gap. Best Pract Res Clin Endocrinol Metab 17: 559-574, 2003
7. Kraut JA, Kurtz I: Toxic alcohol ingestions: Clinical features, diagnosis, and management. Clin J Am Soc Nephrol 3: 208-225, 2008
8. Emmett M: Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): A tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle. Clin J Am Soc Nephrol 9: 191-200, 2014
9. Levraut J, Bounatirou T, Ichai C, Ciais JF, Jambou P, Hechema R, Grimaud D: Reliability of anion gap as an indicator of blood lactate in critically ill patients. Intensive Care Med 23: 417-422, 1997
10. Moviat M, Terpstra AM, RuitenbeekW, Kluijtmans LA, Pickkers P, van der Hoeven JG: Contribution of various metabolites to the "unmeasured" anions in critically ill patients with metabolic acidosis. Crit Care Med 36: 752-758, 2008
11. Adeva-Andany M, López-Ojén M, Funcasta-Calderón R, Ameneiros-Rodríguez E, Donapetry-García C, Vila-Altesor M, Rodríguez-Seijas J: Comprehensive review on lactate metabolism in human health. Mitochondrion 17: 76-100, 2014
12. Scale T, Harvey JN: Diabetes,metformin and lactic acidosis. Clin Endocrinol (Oxf) 74: 191-196, 2011
13. Gray LR, Tompkins SC, Taylor EB: Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci 71: 2577- 2604, 2014
14. Bailey CJ, Turner RC: Metformin. N Engl J Med 334: 574-579, 1996
15. Lalau JD: Lactic acidosis induced by metformin: Incidence, management and prevention. Drug Saf 33: 727-740, 2010
16. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE: Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333: 550-554, 1995
17. Lalau JD, Race JM: Lactic acidosis in metformin therapy: Searching for a link with metformin in reports of 'metforminassociated lactic acidosis.' Diabetes Obes Metab 3: 195-201, 2001
18. Lalau JD, Arnouts P, Sharif A, De Broe ME: Metformin and other antidiabetic agents in renal failure patients. Kidney Int 87: 308- 322, 2015
19. Kirpichnikov D, McFarlane SI, Sowers JR: Metformin: An update. Ann Intern Med 137: 25-33, 2002
20. Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA, Prigaro BJ, Wood JL, Bhanot S, MacDonald MJ, Jurczak MJ, Camporez JP, Lee HY, Cline GW, Samuel VT, Kibbey RG, Shulman GI: Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510: 542-546, 2014
21. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 4: CD002967, 2010
22. BodmerM,Meier C, Krähenbü hl S, Jick SS,Meier CR: Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: A nested case-control analysis. Diabetes Care 31: 2086-2091, 2008
23. Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA: Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 338: 265-266, 1998
24. Kajbaf F, Lalau JD: Mortality rate in so-called "metformin-associated lactic acidosis": A review of the data since the 1960s. Pharmacoepidemiol Drug Saf 23: 1123-1127, 2014
25. Adam WR, O'Brien RC: A justification for less restrictive guidelines on the use ofmetformin in stable chronic renal failure. Diabet Med 31: 1032-1038, 2014
26. Lalau JD, Race JM: Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 20: 377-384, 1999
27. Vecchio S, Giampreti A, Petrolini VM, Lonati D, Protti A, Papa P, Rognoni C, Valli A, Rocchi L, Rolandi L, Manzo L, Locatelli CA: Metformin accumulation: Lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol (Phila) 52: 129-135, 2014
28. Eurich DT, Weir DL, Majumdar SR, Tsuyuki RT, Johnson JA, Tjosvold L, Vanderloo SE, McAlister FA: Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: Systematic review of observational studies involving 34,000 patients. Circ Heart Fail 6: 395-402, 2013
29. Levy B: Bench-to-bedside review: Is there a place for epinephrine in septic shock? Crit Care 9: 561-565, 2005
30. Marsh JD, Margolis TI, Kim D: Mechanism of diminished contractile response to catecholamines during acidosis. Am J Physiol 254: H20-H27, 1988
31. Teplinsky K, O'Toole M, Olman M,Walley KR,Wood LD: Effect of lactic acidosis on canine hemodynamics and left ventricular function. Am J Physiol 258: H1193-H1199, 1990
32. Kraut JA, Kurtz I: Use of base in the treatment of severe acidemic states. Am J Kidney Dis 38: 703-727, 2001
33. Kraut JA, Madias NE: Treatment of acute metabolic acidosis: A pathophysiologic approach. Nat Rev Nephrol 8: 589-601, 2012
34. Rachoin JS, Weisberg LS, McFadden CB: Treatment of lactic acidosis: Appropriate confusion. J Hosp Med 5: E1-E7, 2010
35. Cooper DJ, Walley KR, Wiggs BR, Russell JA: Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med 112: 492-498, 1990
36. Arieff AI, Leach W, Park R, Lazarowitz VC: Systemic effects of NaHCO3 in experimental lactic acidosis in dogs. Am J Physiol 242: F586-F591, 1982
37. Zahler R, Barrett E, Majumdar S, Greene R, Gore JC: Lactic acidosis: Effect of treatment on intracellular pH and energetics in living rat heart. Am J Physiol 262: H1572-H1578, 1992
38. Levraut J, Garcia P, Giunti C, Ichai C, Bouregba M, Ciebiera JP, Payan P,Grimaud D: The increase in CO2 production induced by NaHCO3 depends on blood albumin and hemoglobin concentrations. Intensive Care Med 26: 558-564, 2000
39. Pedersen KO: Binding of calcium to serum albumin. II. Effect of pH via competitive hydrogen and calcium ion binding to the imidazole groups of albumin. Scand J Clin Lab Invest 29: 75-83, 1972
40. Lang RM, Fellner SK, Neumann A, BushinskyDA, BorowKM: Left ventricular contractility varies directly with blood ionized calcium. Ann Intern Med 108: 524-529, 1988
41. Dellinger RP, LevyMM, Carlet JM, Bion J, ParkerMM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, RamsayG, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical- Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society;World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit CareMed 36: 296-327, 2008
42. Fernandez PC, Cohen RM, Feldman GM: The concept of bicarbonate distribution space: The crucial role of body buffers. Kidney Int 36: 747-752, 1989
43. Orchard CH, Kentish JC: Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol 258: C967-C981, 1990
44. CerdÁJ, Tolwani A, Gibney N, Tiranathanagul K: Renal replacement therapy in special settings: Extracorporeal support devices in liver failure. Semin Dial 24: 197-202, 2011
45. Barton IK, Hilton PJ, Treacher DF, Bradley RD: Treatment of combined renal failure and lactic acidosis by haemofiltration. Clin Intensive Care 3: 196-198, 1992
46. Hilton PJ, Taylor J, Forni LG, Treacher DF: Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis. QJM 91: 279-283, 1998
47. Kirschbaum B, Galishoff M, Reines HD: Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagulation. Crit Care Med 20: 349-353, 1992
48. De Corte W, Vuylsteke S, De Waele JJ, Dhondt AW, Decruyenaere J, Vanholder R, Hoste EA: Severe lactic acidosis in critically ill patients with acute kidney injury treated with renal replacement therapy. J Crit Care 29: 650-655, 2014
49. Seidowsky A,Nseir S, HoudretN, Fourrier F:Metformin-associated lactic acidosis: A prognostic and therapeutic study. Crit Care Med 37: 2191-2196, 2009
50. Lalau JD,Andrejak M,Morinière P, Coevoet B,Debussche X,Westeel PF, Fournier A, Quichaud J: Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: A study of metformin elimination. Int J Clin Pharmacol Ther Toxicol 27: 285-288, 1989
51. Dichtwald S, Weinbroum AA, Sorkine P, Ekstein MP, Dahan E: Metformin-associated lactic acidosis following acute kidney injury. Efficacious treatment with continuous renal replacement therapy. Diabet Med 29: 245-250, 2012
52. van Berlo-van de Laar IR, Vermeij CG, Doorenbos CJ: Metformin associated lactic acidosis: Incidence and clinical correlation with metformin serum concentration measurements. J Clin Pharm Ther 36: 376-382, 2011
53. Andersen LW, Mackenhauer J, Roberts JC, Berg KM, Cocchi MN, Donnino MW: Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc 88: 1127-1140, 2013
54. Friesecke S, Abel P, Roser M, Felix SB, Runge S: Outcome of severe lactic acidosis associated with metformin accumulation. Crit Care 14: R226, 2010
55. Glucophage: Glucophage Package Insert. Available at: http:// packageinserts.bms.com/pi/pi_glucophage_xr.pdf. Accessed October 12, 2014
56. Kajbaf F, Arnouts P, de Broe M, Lalau JD: Metformin therapy and kidney disease: A review of guidelines and proposals for metformin withdrawal around the world. Pharmacoepidemiol Drug Saf 22: 1027-1035, 2013
57. Fantus IG: Metformin's contraindications: Needed for now. CMAJ 173: 505-507, 2005
58. Lee Hamm L, Hering-Smith KS, Nakhoul NL: Acid-base and potassium homeostasis. Semin Nephrol 33: 257-264, 2013
59. Fulop M: Serum potassium in lactic acidosis and ketoacidosis. N Engl J Med 300: 1087-1089, 1979